Established in 1960 and headquartered in Nam Định, Vietnam, Nam Ha Pharmaceutical Joint Stock Company (NAPHA PHARMA) is one of the country's most reputable pharmaceutical manufacturers. With over six decades of operational excellence, the company combines traditional Eastern medicine with modern pharmaceutical science to develop and manufacture a wide spectrum of high-quality healthcare products for both domestic and international markets.
Core Business and Product Portfolio
Nam Ha Pharmaceutical’s business is rooted in research, development, and production of pharmaceutical and medicinal products across multiple therapeutic categories. Its extensive portfolio includes:
-
Respiratory Health:
-
Digestion & Hepatobiliary:
-
Eye Care:
-
Antidiabetic:
-
Birth Control:
-
Anti-Tuberculosis:
-
Traditional Medicine:
- An Cung Ngưu Hoàng Hoàn
- Hoạt Huyết Dưỡng Não
-
Vitamins & Minerals:
-
Medical Equipment:
-
Skincare:
-
Osteoarthritis Care:
-
Antibiotics & Antivirals:
- Amoxicillin
- Fluconazole
- Acyclovir
-
Cardiovascular & Nervous System:
-
Pain Relief & Anti-inflammatory:
This broad and diverse range allows the company to serve a wide demographic, from pediatric to geriatric care, across various public and private healthcare segments.
Specialization and Unique Selling Proposition (USP)
Nam Ha Pharmaceutical is especially known for its combination of traditional herbal remedies and modern allopathic drugs, reflecting Vietnam’s dual approach to healthcare. Its iconic product, Bổ Phế Nam Hà, is a household name in Vietnam for treating coughs and respiratory infections using a proprietary herbal formula.
The company's R&D division works closely with the Ministry of Health and national research institutions to innovate within the herbal and synthetic drug domains. NAPHA’s dual capability in Eastern and Western medicine gives it a unique advantage in diversified product development and market reach.
Certifications and Quality Compliance
Nam Ha Pharmaceutical maintains stringent manufacturing protocols aligned with global pharmaceutical standards. Key certifications include:
- GMP-WHO (Good Manufacturing Practices – World Health Organization)
- GLP (Good Laboratory Practices)
- GSP (Good Storage Practices)
- ISO 9001:2015 for Quality Management Systems
These certifications reflect the company’s commitment to maintaining high-quality standards across production, testing, and distribution.
Export and Shipment Records
According to international trade data from platforms like Volza and ImportYeti:
- Nam Ha Pharmaceutical has exported products to over 15 countries, including Laos, Cambodia, Myanmar, and several African nations.
- Estimated export volume surpasses 1,000 shipments between 2017 and 2023.
- Product categories with highest export volumes include cough syrups, antipyretics, and herbal supplements.
- Total estimated export value exceeds USD 10 million during this period.
These figures demonstrate the company’s solid footprint in the regional and global pharmaceutical export market.
Financial and Operational Capabilities
As a joint stock company with backing from Vietnamese state and private investors, Nam Ha Pharmaceutical reports stable annual revenues. Based on financial disclosures and industry estimates:
- Estimated annual revenue ranges between VND 500–700 billion (approx. USD 20–30 million).
- Operates multiple GMP-certified manufacturing lines with an annual production capacity of:
- 300 million tablets
- 100 million capsules
- 50 million syrup bottles
- Tens of millions of medical devices
The company continues to invest in automation, clean room technology, and AI-driven R&D analytics to modernize its infrastructure.
Target Market and Industry Positioning
Nam Ha Pharmaceutical targets both public and private healthcare sectors across Vietnam and developing international markets. Their offerings cater to:
- Hospitals and clinics
- Pharmacies
- Government healthcare programs
- Export partners and distributors
Its dual strength in herbal and synthetic formulations positions the company uniquely in markets seeking cost-effective alternatives to imported Western drugs, especially in respiratory care, chronic disease management, and herbal wellness products.
Recognitions and Industry Engagement
Nam Ha Pharmaceutical is frequently recognized by the Vietnamese Ministry of Health and industry associations:
- Recipient of “Vietnam High-Quality Goods” award for multiple consecutive years
- Regular exhibitor at Vietnam Medi-Pharm Expo and ASEAN Pharma trade fairs
- Collaborates with Vietnam Pharmaceutical Companies Association (VNPCA) for policy and innovation initiatives
The company is also featured in domestic media for its CSR initiatives, including health education programs and rural medical donation drives.
With its enduring legacy, robust product range, and adherence to international quality norms, Nam Ha Pharmaceutical Joint Stock Company continues to play a pivotal role in Vietnam’s pharmaceutical ecosystem and expands steadily into new international frontiers.
